FDA
-
-
-
-
-
-
-
Femasys Strengthens and Extends Global Patent Protection for FemBlocĀ® with First Issued Blended Polymer Patents
-
-
-
-
-
-
-
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
-
-
-
-
-
-
-
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
-
-
-
-
-
-
-
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
-
-
-
-
-
-
-
Femasys Announces Third Quarter Financial Results for 2025
-
-
-
-
-
-
-
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
-
329,910 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

